ClinConnect ClinConnect Logo
Search / Trial NCT06203106

NYSCF Scientific Discovery Biobank

Launched by NEW YORK STEM CELL FOUNDATION RESEARCH INSTITUTE · Jan 2, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Als Amyotrophic Lateral Sclerosis Alzheimer Disease Batten Disease Corticobasal Degeneration Dementia Frontotemporal Dementia Huntington Disease Lewy Body Disease Multiple Sclerosis Multiple System Atrophy Parkinson Disease Parkinsonism Progressive Supranuclear Palsy Inad Diabetes Diabetes Type 1 Diabetes Type 2 Macular Degeneration Women's Reproductive Cancer Ovarian Cancer Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer Ptsd Post Traumatic Stress Disorder

ClinConnect Summary

The NYSCF Scientific Discovery Biobank is a research study designed to help scientists learn more about various diseases, including ALS, Alzheimer’s disease, and several types of cancer. The goal is to use samples from participants, such as skin or blood, to create stem cells and other cells that can be studied. This research aims to uncover potential treatments or cures for these serious health conditions.

To participate, individuals must be at least 30 days old and have a diagnosis of one of the targeted conditions or be a healthy control. Adults who can make decisions will need to give written consent, while those unable to consent due to their condition will require approval from a legal representative. Participants can expect to provide samples for research and may help contribute to important discoveries in medicine. It’s important to note that certain health conditions may prevent someone from joining, so it's best to discuss eligibility with the research team.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 30 days or older.
  • Diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest or healthy control.
  • Adults with decisional capacity must provide written informed consent unless physical limitations preclude signing.
  • Adults without decisional capacity to consent must a have diagnosis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease and Related Dementias (AD/ADRD); Batten Disease, Corticobasal Degeneration (CBD), Dementia, Frontotemporal Dementia (FTD), Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson's Disease (PD), Parkinsonism, and/or Progressive Supranuclear Palsy, and must provide assent; a legally authorized representative (LAR) must also provide written informed consent.
  • Minors undergoing skin collection for research purposes must have a condition, disease, genetic background, or trait of interest and parental/guardian consent.
  • Minors undergoing blood, and/or saliva collection for research purposes may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent.
  • Minors transferring biological samples and associated data from a procedure outside of the research may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent.
  • Exclusion Criteria:
  • Wards of the state.
  • For prospective skin samples: history of keloid formation, coagulation disorder, or allergy to the anesthetic.
  • For prospective blood samples: history of coagulation disorder.
  • For all prospective sample collections: 1) Subjects who refuse to adhere to NYSCF's and/or a collection site's safety protocol(s) will be excluded; 2) Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of blood will be excluded due to increased risk of infection.

About New York Stem Cell Foundation Research Institute

The New York Stem Cell Foundation Research Institute (NYSCF) is a leading nonprofit organization dedicated to advancing stem cell research and regenerative medicine. With a mission to accelerate scientific discovery and translate research into therapies, NYSCF fosters collaboration among scientists, clinicians, and industry partners. The institute is committed to the highest standards of scientific integrity, conducting innovative clinical trials that aim to address unmet medical needs and improve patient outcomes. By leveraging cutting-edge technology and expertise, NYSCF seeks to unlock the potential of stem cells to transform healthcare and enhance the quality of life for individuals with a range of medical conditions.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Laura Andres-Martin, PhD

Principal Investigator

New York Stem Cell Foundation Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported